Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 4Genitourinary 2

Conditions

Prostatic Neoplasms 3Hot Flashes 2Urinary Bladder Neoplasms 1Anxiety Disorders 1

Interventions

Acupuncture Therapy 4liposomal amphotericin B 2Venlafaxine Hydrochloride 2Isoflavones 2Gabapentin 2Caspofungin 2fezolinetant 1Vitamin B 6 1Therapeutics 1Sugars 1Soybean Proteins 1Goserelin 1Estradiol 1Estetrol 1Cyproterone Acetate 1Caseins 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hot Flashes × Gabapentin × Genitourinary × Clear all
NCT01533753 2019-11-21

Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer

University of Wisconsin, Madison

Phase 2 Terminated
5 enrolled 5 charts
Genitourinary

Prostatic Neoplasms, Hot Flashes

NCT00028574 2016-06-28

Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
223 enrolled
Genitourinary

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡